PetMed Express Ownership
| PETS Stock | USD 4.08 0.04 0.99% |
Shares in Circulation | First Issued 2000-03-31 | Previous Quarter 20.9 M | Current Value 20.6 M | Avarage Shares Outstanding 20.7 M | Quarterly Volatility 3.2 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
PetMed |
PetMed Stock Ownership Analysis
About 22.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.87. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. PetMed Express has Price/Earnings To Growth (PEG) ratio of 2.58. The entity last dividend was issued on the 11th of August 2023. The firm had 959692:319 split on the 4th of March 1999. PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida. Petmed Express operates under Pharmaceutical Retailers classification in the United States and is traded on NASDAQ Exchange. It employs 212 people. To find out more about PetMed Express contact Sandra Campos at 561 526 4444 or learn more at https://www.1800petmeds.com.Besides selling stocks to institutional investors, PetMed Express also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different PetMed Express' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align PetMed Express' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
PetMed Express Quarterly Liabilities And Stockholders Equity |
|
PetMed Express Insider Trades History
About 22.0% of PetMed Express are currently held by insiders. Unlike PetMed Express' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against PetMed Express' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of PetMed Express' insider trades
PetMed Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as PetMed Express is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading PetMed Express backward and forwards among themselves. PetMed Express' institutional investor refers to the entity that pools money to purchase PetMed Express' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | D. E. Shaw & Co Lp | 2024-12-31 | 172 K | Ubs Group Ag | 2024-12-31 | 150.8 K | Amvescap Plc. | 2024-12-31 | 148.8 K | Invenomic Capital Management, Lp | 2024-12-31 | 148.4 K | Ameriprise Financial Inc | 2024-12-31 | 146.4 K | Man Group Plc | 2024-12-31 | 145.8 K | Millennium Management Llc | 2024-12-31 | 144.1 K | Formidable Asset Management Llc | 2024-12-31 | 135.3 K | T. Rowe Price Associates, Inc. | 2024-12-31 | 121.7 K | Renaissance Technologies Corp | 2024-12-31 | 1.3 M | Hotchkis & Wiley Capital Management Llc | 2024-12-31 | 974.1 K |
PetMed Express Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific PetMed Express insiders, such as employees or executives, is commonly permitted as long as it does not rely on PetMed Express' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases PetMed Express insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
PetMed Express Outstanding Bonds
PetMed Express issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. PetMed Express uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most PetMed bonds can be classified according to their maturity, which is the date when PetMed Express has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
PetMed Express Corporate Filings
F4 | 19th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 10th of March 2025 Other Reports | ViewVerify | |
| 14th of February 2025 Other Reports | ViewVerify | |
8K | 10th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for PetMed Stock Analysis
When running PetMed Express' price analysis, check to measure PetMed Express' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PetMed Express is operating at the current time. Most of PetMed Express' value examination focuses on studying past and present price action to predict the probability of PetMed Express' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PetMed Express' price. Additionally, you may evaluate how the addition of PetMed Express to your portfolios can decrease your overall portfolio volatility.